Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE inhibition in Fontan patients: effect on body fluid regulation
2016-004433-24Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of enalapril in Single Ventricle Heart Defects, sponsored by Leiden University Medical Center. Primary endpoints: Echocardiography and hemodynamic assessment and Autonomic and vascular function comparison. Started Feb 2017; status: completed.
02
Drugs
enalapril
03
Conditions
Single Ventricle Heart Defects
Beyond the preview
Go deeper on 2016-004433-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004433-24.